BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Bleomycin
,
rs3825942
,
MDM2
,
Coagulation
,
Obesity
,
Embryo
,
Early pregnancy factor
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
grave disease
Summary
General Info
Curated Studies
Most Correlated Studies
OMIM - Thyroid disease
OMIM - Graves' disease
Colon cancer HCA-7 cells resistant to cetuximab in 3D-culture
Acute lymphoblastic leukemia cell lines SUP-B8 and NALM-6 after GSK126 (EZH2 inhibitor) treatment
Subcutaneous adipose tissue from canines fed ad libitum or maintained on weight control diet
Explore Curated Studies Results
Literature
Most Relevant Literature
Preoperative preparation for Graves' disease.
Surgical management of Graves' disease: historical context and single institution experience.
Chronic Myopathy as the Initial Manifestation of Thyrotoxicosis: A Report of 2 Cases.
Acute suppurative thyroiditis with Graves disease - A very rare association.
The value of FT4/TSH ratio in the differential diagnosis of Graves' disease and subacute thyroiditis…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
TSI and Its Relationship With Graves' Disease Relapse
Observation in the Treatment of Graves' Disease
Remission Induction and Sustenance in Graves' Disease 2
Change of Gut Microbiome in the Treatment of Graves' Disease
Subtotal Versus Total Thyroidectomy for Graves' Disease
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ